Home » Topics » Science » New compound

New compound
RSS

More possible Alzheimer's treatment

June 14, 1996

XSB-1E as possible Alzheimer's treatment

June 14, 1996

MF-8622 undergoes preclinical evaluation

June 14, 1996

ZK-138723: Schering AG's aromatase inhibitor

June 14, 1996

GR-92754: Most effective DHFR inhibitor

June 14, 1996

NN-42-1007: First potent and selective hepatic glycogen phosphorylase inhibitor

June 7, 1996

TZA-2209: A pure aromatase inhibitor

June 7, 1996

Warner-Lambert reveals indole endothelin antagonists

June 7, 1996

SJC13: LPS-stimulated adhesion inhibitor

June 7, 1996

GR-205171: A non-peptide neurokinin NK1 antagonist

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...